Pegylated liposomal doxorubicin in the management of ovarian cancer

Among the pharmaceutical options available for treatment of ovarian cancer, much attention has been progressively focused on pegylated liposomal doxorubicin (PLD), whose unique formulation, which entraps conventional doxorubicin in a bilayer lipidic sphere surrounded by a polyethylene glycol layer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrandina, Gabriella, Corrado, Giacomo, Licameli, Angelo, Lorusso, Domenica, Fuoco, Gilda, Pisconti, Salvatore, Scambia, Giovanni
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952486/
https://www.ncbi.nlm.nih.gov/pubmed/20957139
http://dx.doi.org/10.2147/TCRM.S3348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952486/
https://www.ncbi.nlm.nih.gov/pubmed/20957139
http://dx.doi.org/10.2147/TCRM.S3348

Ejemplares similares